Duminuco, A.; Nardo, A.; Garibaldi, B.; Vetro, C.; Longo, A.; Giallongo, C.; Di Raimondo, F.; Palumbo, G.A.
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting. J. Clin. Med. 2022, 11, 7418.
https://doi.org/10.3390/jcm11247418
AMA Style
Duminuco A, Nardo A, Garibaldi B, Vetro C, Longo A, Giallongo C, Di Raimondo F, Palumbo GA.
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting. Journal of Clinical Medicine. 2022; 11(24):7418.
https://doi.org/10.3390/jcm11247418
Chicago/Turabian Style
Duminuco, Andrea, Antonella Nardo, Bruno Garibaldi, Calogero Vetro, Anna Longo, Cesarina Giallongo, Francesco Di Raimondo, and Giuseppe A. Palumbo.
2022. "Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting" Journal of Clinical Medicine 11, no. 24: 7418.
https://doi.org/10.3390/jcm11247418
APA Style
Duminuco, A., Nardo, A., Garibaldi, B., Vetro, C., Longo, A., Giallongo, C., Di Raimondo, F., & Palumbo, G. A.
(2022). Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting. Journal of Clinical Medicine, 11(24), 7418.
https://doi.org/10.3390/jcm11247418